New implant aims to stop Post-Prostate surgery leaks

NCT ID NCT03650244

Ongoing Disease control Sponsor: Centre Hospitalier Universitaire de Nīmes Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 100 men who have had prostate surgery and still struggle with stress urinary incontinence (leaking urine when coughing or moving). They receive an adjustable implant called REMEEX to help control leakage. Researchers will track how well it works, side effects, and quality of life over 5 years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: REMEEX implant (adjustable medical device)
What this could lead to: If successful, this could confirm REMEEX as a reliable option for men with persistent incontinence after prostate surgery, improving quality of life.
What could go wrong: This is an observational study, not a controlled trial, so results may be less definitive. The device involves surgery and carries risks like infection or device malfunction.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for URINARY INCONTINENCE,STRESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

female stress incontinence Urinary Incontinence, Stress

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

URINARY INCONTINENCE,STRESS

Contacts and locations

Locations

APHP Hôpital Henry Mondor

Créteil, 94000, France
CHU Nancy

Nancy, France
CHU Nice

Nice, France
CHU Nimes

Nîmes, 30029, France
CHU Strasbourg

Strasbourg, France
CHU Toulouse

Toulouse, France
CHU de Besançon

Besançon, France
CHU de Dijon

Dijon, France
CHU de Limoges

Limoges, France
Hôpital Foch

Suresnes, 92151, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.